Abstract:
A process and apparatus (20) for purifying one or more target substances from a source liquid, employing one or more cross-flow filter elements (27), and one or more types of chromatography resins, in combination, to provide purification with advantageous yield, product purity, and cost- and time-efficiency.
Abstract:
An antibody/carrier complex which makes it possible to easily control the sensitivity in an antigen-antibody reaction without newly constructing an antibody. This antibody/carrier complex is a complex containing at least one antibody and has a polymer structure wherein each antigen-binding site of the antibody is arranged so as to react with the antigen.
Abstract:
The invention relates to a cellulose film comprising microfibrillated cellulose and to the use of it for screening of a biological compound. The invention further relates to a cellulose film for screening for nucleic acids encoding a biological compound.
Abstract:
The invention provides novel techniques for derivatizing colloids with self-assembled monolayers. This provides the capability of a wide variety of assays including chemical or biochemical agent/agent interaction studies. Bio-derivatized colloids, with or without signaling entities, are used to probe interactions with species on non-colloidal structures. The invention provides techniques for immobilizing colloidal particles on a wide variety of non-colloidal structures. Included is the ability to decorate a variety of non-colloidal structures including beads, with colloids as a detectable assay. This allows, in many cases, assays detectable via the unaided human eye, as well as assays detectable via automated determination of a change of interaction of electromagnetic radiation with the colloids, e.g., absorption, light-scattering, and the like.
Abstract:
The invention provides novel techniques for derivatizing colloids with self-assembled monolayers. This provides the capability of a wide variety of assays including chemical or biochemical agent/agent interaction studies. Bio-derivatized colloids, with or without signaling entities, are used to probe interactions with species on non-colloidal structures. The invention provides techniques for immobilizing colloidal particles on a wide variety of non-colloidal structures. Included is the ability to decorate a variety of non-colloidal structures including beads, with colloids as a detectable assay. This allows, in many cases, assays detectable via the unaided human eye, as well as assays detectable via automated determination of a change of interaction of electromagnetic radiation with the colloids, e.g., absorption, light-scattering, and the like.
Abstract:
The invention concerns a method for isolating at least an analyte (4) in a medium, in which it is distributed, consisting in: (a) providing at least one reagent (3) comprising a free support, in discrete form, exhibiting at least a receptor of the analyte; (b) providing another capture support, the accessible surface of which comprises at least an effective or active zone, of limited surface, exhibiting at least another receptor (10) of an entity to be captured, viz. of said analyte or said receptor; (c) contacting the reagent (3) with a liquid sample obtained from the medium containing the analyte, for forming an intermediate medium comprising, also in discrete form and distributed in said medium, a complex between said support, the receptor and the analyte; (d) contacting the accessible surface of said other support with at least a capture reactant, viz. the reagent that has not reacted during step (c) or the complex, for binding said capture reactant to said accessible surface, and obtaining a concentrated deposit in said effective zone, fixed on said other support by the bond of said other receptor with said receptor or analyte; (e) concentrating the deposit of said capture reactant in said effective zone, by increasing the amount of said reactant per surface unit in said effective zone.
Abstract:
The invention relates to the production of multiple-application patient-specific immunoadsorbents which can be used for extracorporal apheresis in patients suffering from disorders caused by dysregulation of the immune system. Conventional methods are used to isolate the immune complexes from the patient's blood and appropriate methods are applied to separate the immune complexes into antigens and antibodies. The antigens and antibodies thus reactivated are coupled individually or as a mixture covalently to suitable carriers which are used as immunoadsorbents for the patient from whom the immune complexes originate. This facilitates production of specific immunoadsorbents even for patients suffering from rare auto-immune diseases.
Abstract:
The invention relates to methods and systems of unhindered construction and display of tethered organic ligand molecules, and more particularly to preparation and use of thin film, substantially non-crosslinked hydrophilic polar multi-functionalized polymers (HPMPs) anchored to a variety of functionalized substrates so that the HPMP forms a thin film matrix layer providing a unique, highly hydrated, high dielectric environment equivalent to an aqueous solution, for affinity binding of Ligands (L) to Tagged Target Molecules (TTMs).
Abstract:
본 발명은 인플루엔자 바이러스 유래 뉴클레오캡시드 단백질(NP)에 특이적으로 결합하는 앱타머 및 상기 앱타머를 검출하기 위한 복합체를 포함하는 인플루엔자 바이러스 검출용 조성물, 상기 조성물을 포함하는 인플루엔자 바이러스 검출용 키트, 상기 조성물 또는 키트를 사용하여 인플루엔자 바이러스의 감염여부 확인에 필요한 정보를 제공하는 방법 및 인플루엔자 감염여부 확인을 위한 상기 조성물의 용도에 관한 것이다. 본 발명에서 제공하는 앱타머를 이용한 인플루엔자 바이러스 검출방법을 이용하면, 환자가 인플루엔자 바이러스에 감염되었는지의 여부를 높은 민감도와 특이도로서 검출할 수 있으므로, 인플루엔자 바이러스의 보다 효과적인 치료에 널리 활용될 수 있을 것이다.